Literature DB >> 10529258

Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity.

J Wall1, M Schell, C Murphy, R Hrncic, F J Stevens, A Solomon.   

Abstract

Certain types of human light chains have the propensity to deposit pathologically as amyloid fibrils as evidenced by the preferential association of monoclonal lambda 6 proteins with AL amyloidosis. However, the molecular features that render such proteins amyloidogenic have not been elucidated. Based upon the demonstrated relationship between the thermodynamic stability of light chains and their propensity to aggregate in vitro, we have initiated studies where the thermodynamic properties and fibrillogenic potential of two recombinant (r) V lambda 6 molecules were compared. The first protein was generated from cDNA cloned from marrow-derived plasma cells from a patient (Wil) who had AL amyloidosis and renal amyloid deposits; the second was from a patient (Jto) with multiple myeloma in whom the lambda 6 protein was deposited not as amyloid but in the form of renal tubular casts. The thermodynamic stabilities of rV lambda 6Wil and -Jto were determined from chaotropic and thermal denaturation studies. Based upon the Delta GH2O, Delta H, Delta G25 degrees C, Tm, and Cm values, the rV lambda 6Wil was less stable than its nonamyloidogenic counterpart, rV lambda 6Jto. Measurement of fibril formation using a novel in vitro fibril forming assay demonstrated that although both rV lambda 6 proteins formed fibrils in vitro, Wil had a shorter lag time and exhibited faster kinetics under physiologic conditions. Comparative amino acid sequence analyses of these two components and other lambda 6 amyloid-associated light chains revealed that the Jto protein had certain primary structural features that we posit contributed to its increased stability and thus rendered this protein nonamyloidogenic. Our studies provide the first evidence that stabilizing interactions within the V L domain can influence the kinetics of light chain fibrillogenicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529258     DOI: 10.1021/bi991131j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  76 in total

1.  A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro.

Authors:  M Ramirez-Alvarado; J S Merkel; L Regan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Mutations in the B1 domain of protein G that delay the onset of amyloid fibril formation in vitro.

Authors:  Marina Ramírez-Alvarado; Melanie J Cocco; Lynne Regan
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

3.  Antibody-mediated resolution of light chain-associated amyloid deposits.

Authors:  R Hrncic; J Wall; D A Wolfenbarger; C L Murphy; M Schell; D T Weiss; A Solomon
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL).

Authors:  Roshini S Abraham; Susan M Geyer; Marina Ramírez-Alvarado; Tammy L Price-Troska; Morie A Gertz; Rafael Fonseca
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

5.  The use of native cation-exchange chromatography to study aggregation and phase separation of monoclonal antibodies.

Authors:  Shuang Chen; Hollis Lau; Yan Brodsky; Gerd R Kleemann; Ramil F Latypov
Journal:  Protein Sci       Date:  2010-06       Impact factor: 6.725

6.  Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.

Authors:  Marta Marin-Argany; Jofre Güell-Bosch; Luis M Blancas-Mejía; Sandra Villegas; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2015-09-07       Impact factor: 6.725

7.  Dissociation of recombinant prion protein fibrils into short protofilaments: implications for the endocytic pathway and involvement of the N-terminal domain.

Authors:  Xu Qi; Roger A Moore; Michele A McGuirl
Journal:  Biochemistry       Date:  2012-05-23       Impact factor: 3.162

8.  The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.

Authors:  Richard W McLaughlin; Janelle K De Stigter; Laura A Sikkink; Elizabeth M Baden; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

9.  Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro.

Authors:  Abdessamad Tahiri-Alaoui; William James
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

Review 10.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.